Chris Boneham

Chris Boneham has extensive experience in market access and managed markets within the pharmaceutical industry. Chris is currently working at Y-mAbs Therapeutics, Inc. as the Vice President of Market Access since January 2022. Prior to this role, they served as the Head of Market Access US at the same company from February 2019 to January 2022.

Before joining Y-mAbs Therapeutics, Inc., Chris worked at Aralez Pharmaceuticals Inc. as the Executive Director of Managed Markets from July 2015 to January 2019. Chris also held the position of Director of Trade, Reimbursement and Access at Vanda Pharmaceuticals from June 2013 to July 2015.

Chris has experience in commercial contracting and consulting as well, having worked at Pharmaceutical Consulting from February 2012 to June 2013. Prior to that, they worked at Chelsea Therapeutics as the Director of Trade and Distribution from August 2011 to March 2012.

In their earlier career, Chris held roles at Acorda Therapeutics as the Director of National Accounts from July 2009 to July 2011 and at Oscient Pharmaceuticals as the Director of National Accounts East from October 2008 to April 2009. Chris also worked at Daiichi Sankyo as a Corporate Account Manager from March 2006 to October 2008 and at Alpharma as the National Director of Managed Markets from October 2002 to February 2006, where they also served as the Associate Director of Managed Care.

Overall, Chris Boneham has a strong background in market access, managed care, and pharmaceutical consulting, with extensive experience in negotiating and developing relationships with key national and regional managed care organizations.

Chris Boneham attended Indiana University at Bloomington from 1984 to 1989. Chris graduated with a Bachelor of Science degree in Exercise Physiology.